Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Net Margin (2017 - 2025)

Catheter Precision (VTAK) has disclosed Net Margin for 9 consecutive years, with 1876.47% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 536246.0% to 1876.47% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1972.77% through Dec 2025, up 321794.0% year-over-year, with the annual reading at 2098.05% for FY2025, 309267.0% up from the prior year.
  • Net Margin for Q4 2025 was 1876.47% at Catheter Precision, down from 968.14% in the prior quarter.
  • The five-year high for Net Margin was 61600.0% in Q3 2021, with the low at 168960.0% in Q2 2022.
  • Average Net Margin over 5 years is 16950.77%, with a median of 2828.67% recorded in 2025.
  • The sharpest move saw Net Margin tumbled -16843771bps in 2022, then surged 16731833bps in 2023.
  • Over 5 years, Net Margin stood at 61600.0% in 2021, then plummeted by -374bps to 168960.0% in 2022, then soared by 100bps to 522.66% in 2023, then plummeted by -1285bps to 7238.93% in 2024, then surged by 74bps to 1876.47% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 1876.47%, 968.14%, and 2574.53% for Q4 2025, Q3 2025, and Q2 2025 respectively.